Home >> Industry News >> Companies
  • Also available via:

Kering Eyewear and Maison Cartier Establish Strategic Partnership PDF
Submit Your News
Thursday, 23 March 2017

Cartier EyewearKering Eyewear and the Maison Cartier, owned by Compagnie Financière Richemont, plan to enter into a strategic partnership bringing their operations together to create a stronger platform for the development, manufacturing and worldwide distribution of the Cartier eyewear collection. This project is subject to clearance by antitrust authorities.

Under the terms of the agreement, Richemont will acquire a minority stake in Kering Eyewear, a specialised company fully dedicated to the eyewear activity of twelve brands of the Kering Group (Gucci, Bottega Veneta, Saint Laurent, Alexander McQueen, Brioni, Christopher Kane, McQ, Stella McCartney, Tomas Maier, Boucheron, Pomellato and Puma). Kering Eyewear will notably integrate the Manufacture Cartier Lunettes entity in Sucy-en-Brie, France.

Subject to closing, the Cartier 2018 Spring Summer collection, which will be presented during the forthcoming Silmo in Paris (October 6-9, 2017), will mark the official beginning of the partnership.

Safilo Launches Digital Eyewear Museum PDF
Submit Your News
Wednesday, 22 March 2017

Digital Eyewear Museum - SafiloLaunched at MIDO 2017, is the newest digital museum entirely dedicated to eyewear, its history and technology, and its everlasting charm. According to the company, it is a project that highlights the role of Safilo Group as the historical leader and founder of the Italian Eyewear manufacturing tradition, the forerunner of the industry, as well as the company that owns one of the most important private collections dedicated to Eyewear in the world, collected over many years in the memory of its historical owner Guglielmo Tabacchi.

Designed for global smart-visitors, as well as for scholars, researchers and for those who are curious about the history of costume and the eyewear industry, is a Cloud-based digital project that allows visitors to discover, experience and share the wonder of a museum visit from the preferred device, making the most of social networks with intuitive features and language.

Every guest visiting the will have the opportunity to register and create a personal gallery, selecting and downloading the favorite pieces from the 300 unique pieces of Safilo’s permanent collection on display. This includes glasses that belonged to Elvis Presley, Madonna and Elton John, ancient and contemporary artworks – all classified by genre (ancient, modern, active, celebrities, lifestyle, art, science), historical period (from the seventeenth to the twenty-first century), brand (Safilo, Polaroid, Carrera, Smith) – that can be shared in social networks, tagging friends and involving them in the discovery.

In addition to the permanent collection – which will be progressively enriched by showcasing additional items from the collection of 3000 pieces – will propose a calendar of events and temporary exhibitions, dedicated to locations, personalities, new or unseen objects particularly significant for the eyewear world. This is an opportunity that Safilo offers also to its customers, collectors, and fashion brands who wish to collaborate and make use of this unique exhibition space, which can be consulted worldwide.

IDx and IBM Watson Health Forge Alliance for Eye Health PDF
Submit Your News
Monday, 20 March 2017

IBM Watson HealthIBM Watson Health and IDx, LLC recently announced a five-year strategic alliance to advance eye health through cognitive computing applications. The alliance aims to help primary care providers, hospitals, health systems, and integrated delivery networks deliver value-based care to patients with diabetic retinopathy and other serious eye conditions such as glaucoma and age-related macular degeneration. The alliance expands IBM Watson Health's focus on eye health.

The alliance leverages more than a decade of IDx's ophthalmic image analysis work and IBM's cognitive healthcare offerings and global reach. As part of the alliance, IBM Watson Health has the option to distribute IDx offerings. Initially, IBM Watson Health intends to distribute IDx-DR -- an automated solution for diabetic retinopathy screening currently available in the 31 countries that comprise the European Economic Area. IBM Watson Health may expand its distribution of IDx-DR to Australia, Canada, and the United States upon regulatory approvals of the product.

There are 415 million adults with diabetes across the world today, with the number expected to grow by 50% to over 600 million by 2040. Each of these individuals is at high risk of developing diabetic retinopathy, which is one of the leading causes of preventable blindness in working age adults. Most people that develop diabetic retinopathy have no symptoms until irreversible vision loss had occurred, making early disease detection critical to prevent blindness.

"Over the past decades, productivity in healthcare has not kept pace with other sectors. Patients and providers worldwide are paying the price. Our mission at IDx has always been to transform the quality, accessibility, and affordability of global healthcare through the automation of medical screening to support physicians' diagnoses. We are incredibly pleased to partner with IBM Watson Health, which shares this vision, and believe they will help us scale the IDx mission to its fullest potential," said Dr. Michael Abramoff, Founder and President of IDx.

"IDx-DR complements Watson's existing focus in eye health and brings to Watson a novel, secure server-based screening technology that prioritizes patient safety -- pairing expert clinician knowledge with transparent, human brain-inspired algorithms," said Anne Le Grand, vice president of Imaging for Watson Health.

It is further the intent of IBM and IDx to work together to jointly develop and deploy new eye-related offerings leveraging each company's expertise and assets.

This announcement comes shortly after IBM announced that IDx joined the global IBM Watson medical imaging collaborative, which includes 24 members worldwide. The collaborative has a working group on eye health which aims to accelerate Watson's understanding of a range of high-impact diseases -- such as glaucoma, age-related macular degeneration, and cardiovascular disease -- using various imaging modalities including fundus and optical coherence tomography (OCT).

IDx-DR version 2.0 has CE marking as a Class IIa Medical Device for sale in the European Union. IDx products have not yet been cleared by the FDA and are not currently for sale in the United States. IDx is currently conducting a U.S.-based clinical trial of IDx-DR scheduled for completion this summer.

Allergan and Editas Medicine Enter into Strategic R&D Alliance PDF
Submit Your News
Friday, 17 March 2017

CRISPAllergan and Editas Medicine Inc., a genome editing company, recently announced that Allergan's wholly-owned subsidiary, Allergan Pharmaceuticals International Limited, and Editas Medicine have entered into a strategic research and development alliance under which Allergan will receive exclusive access and the option to license up to five of Editas Medicine's genome-editing ocular programs, including its lead program for Leber Congenital Amaurosis (LCA10), which is currently in pre-clinical development.

The agreement covers early stage, first-in-class ocular programs targeting serious diseases based on Editas Medicine's unparalleled CRISPR genome editing platform, including CRISPR/Cas9 and CRISPR/Cpf1. Editas Medicine's lead program is being developed for the potential treatment of LCA10, a rare, inherited retinal degenerative disease that appears in childhood and leads to blindness.

"The CRISPR genome editing platform holds the potential to transform the treatment of many genetic and non-genetically derived diseases, including diseases and conditions of the eye," said David Nicholson, Chief Research and Development Officer, Allergan. "The Allergan team is excited to work with colleagues at Editas Medicine to develop and potentially deliver game-changing treatment for retinal diseases like LCA10. This program is highly complementary to our ongoing eye care development programs where unmet medical need exists for patients."

"Allergan has long been a leader in advancing innovative therapies to treat eye diseases," said Katrine Bosley, President and Chief Executive Officer, Editas Medicine. "Working together with Allergan through their Open Science R&D model significantly enhances our ability to develop genome editing medicines to help patients with serious eye diseases. This alliance is highly aligned with our strategy to build our company for the long-term and to realize the broad potential of our genome editing platform to treat serious diseases."

De Rigo Vision and Chopard Announce Collaboration Renewal PDF
Submit Your News
Monday, 13 March 2017

De Rigo - ChopardDe Rigo Vision and Chopard, the fine watch and jewelry company, have announced the continuation of their partnership to design, produce and distribute worldwide Chopard Eyewear prescription glasses and sunglasses.

De Rigo Group Chairman Ennio De Rigo declared, “We are very proud of the human and professional relationship that has tied us to the Scheufele family and the Chopard brand for over ten years. The early renewal of our partnership strengthens a collaboration that will allow us to seize new growth opportunities for this exclusive and prestigious brand”.

Caroline Scheufele, Co-President and Artistic Director of Chopard added: « We are thrilled to pursue this successful partnership with the De Rigo family. Chopard’s spirit and essence is captured and represented in all the eyewear and sunglasses the expert hands of De Rigo’s finest craftsmen have created. We are proud to present this splendid and refined new collection worldwide in our Chopard Boutique”.

The similarities between eyewear and jewels are profound and refined. Each Chopard glass undergo several quality controls in order to ensure perfection, the prescription glasses are 23 kt gold plated  and crystals are strictly applied by hand.

Kylie Minogue Launches Debut Eyewear Collection for Specsavers PDF
Submit Your News
Friday, 10 March 2017

Kylie Minogue EyewearPop sensation and style icon Kylie Minogue unveiled her new Kylie Minogue Eyewear collection, exclusive to Specsavers, in Sydney on Tuesday morning. The event was attended by more than 60 VIP guests who were treated to a fashion show displaying 25 glasses and four sunglasses from the collection.

Kylie describes the collection as a mix of modern classics, subtle bling and reinvented vintage, drawing inspiration from different eras in a variety of shapes, colours and textures. Each frame features a striking angled temple and her iconic ‘K’ tag for a chic but understated hint of Kylie glamour.

Kylie says, “Designing the glasses and collaborating with Specsavers has been a fabulous experience. I’ve taken a lot of inspiration from the idea of modern classics, popular shapes and styles that suit most people, but with my own personal twist on each frame.”

“I first started wearing glasses when I was in my early twenties. I’d been experiencing headaches and had difficulty maintaining focus when reading, so I had my eyes tested and I’ve been a specs wearer ever since. Expressing yourself with your glasses provides a fantastic opportunity to change up your look, which I personally love to do, so having a real mixture of styles is definitely something that works for me. I like to combine that functional day-to-day look with a little more glamour for the evening. That’s something I’ve incorporated into the collection, through what I like to call a hint of subtle bling!”

Discussing why she’s excited to be launching the Kylie Minogue Eyewear collection, Kylie said, “Designing the glasses and collaborating with Specsavers has been a fabulous experience. I’ve taken a lot of inspiration from the many frames I’ve collected over the years, style icons I admire and classic shapes and styles. I started noticing the different glasses people were wearing and was always assessing what I liked about them. I also found that glasses are not only essential or practical for some people, but others like to wear them just for fashion. What’s more, so many people find them sexy! At my request, we made sure the collection includes some petite styles. I know what it’s like searching for glasses and not being able to find any that fit. We’ve really made sure there’s something in there for everyone.”

The Kylie Minogue Eyewear collection will be available in Specsavers stores from Thursday, March 9th.

More information on the collection can be found at:

<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>

Page 1 of 136